Kenichiro Sato. Worthwhile to whom? Public expectations and the value of lecanemab. // Psychiatry and Clinical Neurosciences. – 2026. – DOI: 10.1111/pcn.70171. – URL: https://onlinelibrary.wiley.com/doi/10.1111/pcn.70171?af=R
Kenichiro Sato (2026). Worthwhile to whom? Public expectations and the value of lecanemab. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.70171
Kenichiro Sato. “Worthwhile to whom? Public expectations and the value of lecanemab.” Psychiatry and Clinical Neurosciences, 2026. doi:10.1111/pcn.70171.
@article{Sato2026,
title = {Worthwhile to whom? Public expectations and the value of lecanemab},
author = {Sato, Kenichiro},
journal = {Psychiatry and Clinical Neurosciences},
year = {2026},
doi = {10.1111/pcn.70171},
url = {https://onlinelibrary.wiley.com/doi/10.1111/pcn.70171?af=R}
}